Uffe H. Olesen

Single application of topical laser- assisted Vismodegib in a microemulsion formulation delivers clinically relevant intratumoral drug concentrations and reduces expression of hedgehog target genes in human basal cell carcinomas

Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU)·2023

Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser

13 cited

Cancers·2022· 13 citedOpen Access

Topical Delivery of Hedgehog Inhibitors: Current Status and Perspectives

12 cited

International Journal of Molecular Sciences·2022· 12 citedOpen Access

Repeated exposure to fractional CO2 laser delays squamous cell carcinoma formation and prevents clinical and subclinical photodamage visualized by line‐field confocal optical coherence tomography and histology

12 cited

Lasers in Surgery and Medicine·2022· 12 citedOpen Access

Optical Imaging Visualizes a Homogeneous and Horizontal Band-Like Biodistribution of Large- and Small-Size Hydrophilic Compounds Delivered by Ablative Fractional Laser

2 cited

Pharmaceutics·2022· 2 citedOpen Access

In vivo dermal delivery of bleomycin with electronic pneumatic injection: drug visualization and quantification with mass spectrometry

2 cited

Expert Opinion on Drug Delivery·2022· 2 citedOpen Access

Ablative fractional laser treatment of basal cell carcinoma increases early immune infiltration and polarizes macrophages towards a wound-healing phenotype

Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU)·2022

Anti-PD-1 Therapy with Adjuvant Ablative Fractional Laser Improves Anti-Tumor Response in Basal Cell Carcinomas

8 cited

Cancers·2021· 8 citedOpen Access

Topical delivery of PD‐1 inhibitors with laser‐assisted passive diffusion and active intradermal injection: Investigation of cutaneous pharmacokinetics and biodistribution patterns

5 cited

Lasers in Surgery and Medicine·2021· 5 citedOpen Access

Laser Immunotherapy: A Potential Treatment Modality for Keratinocyte Carcinoma

9 cited

Cancers·2021· 9 citedOpen Access

page 1 of 3Next →

Frequent Co-authors

Merete Hædersdal(34), Catharina M. Lerche(15), Maxwell Sehested(7), Thomas L. Andresen(7), Christian Janfelt(6), Kristoffer Hendel(6), Rikke Louise Christensen(6), Kristian Kåber Pedersen(5), Martin Wiinberg(5), Fredrik Björkling(4), Peter Buhl Jensen(4), Søren Jensby Nielsen(4), Annemette Thougaard(4), Emily Wenande(4), Gael Clergeaud(4), Charlotte Bagger(4), Liora Bik(4), Martijn B. A. van Doorn(4), R. Rox Anderson(3), Mette Krogh Christensen(3)